Skye ac­quires Bird Rock Bio, weeks af­ter No­vo Nordisk says it will buy a CB1 de­vel­op­er

Skye Bio­science ac­quired Bird Rock Bio to get its hands on an as­set tar­get­ing CB1 just two weeks af­ter No­vo Nordisk dipped its toes in­to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.